Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy

Jayant S Vaidya; Frederik Wenz; Jeffrey S Tobias

doi:10.1136/ebmed-2017-110849

Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy

BMJ Evid Based Med. 2018 Feb;23(1):38-39. doi: 10.1136/ebmed-2017-110849.

Authors

Jayant S Vaidya¹, Frederik Wenz², Jeffrey S Tobias³

Affiliations

¹ Division of Surgery and Interventional Science, University College London, London.
² Department of Radiation Oncology, University of Heidelberg, Mannheim, Germany.
³ Department of Clinical Oncology, University College London, London, UK.

PMID: 29367327
DOI: 10.1136/ebmed-2017-110849

No abstract available

Keywords: Breast cancer; IORT; TARGIT; intraoperative radiotherapy; lumpectom; partial breast irradiation (PBI); patient benefit; targeted radiotherapy.

Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy

Authors

Affiliations

Publication types

MeSH terms

Grants and funding